Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ: IMDX · Real-Time Price · USD
1.970
+0.310 (18.67%)
At close: Nov 20, 2026, 4:00 PM EST
1.940
-0.030 (-1.52%)
After-hours: Nov 20, 2026, 7:57 PM EST
IMDX Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, IMDX stock has a consensus rating of "Buy" and an average price target of $6.50. The average 1-year stock price forecast is 229.95% higher than the current stock price, while the lowest is $4.00 (+103.05%) and the highest is $9.00 (+356.85%).
Price Target: $6.50 (+229.95%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for IMDX stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Buy Maintains $12 → $9 | Buy | Maintains | $12 → $9 | +356.85% | Nov 20, 2026 |
| Lucid Capital | Lucid Capital | Buy Maintains $8 → $4 | Buy | Maintains | $8 → $4 | +103.05% | Nov 17, 2026 |
| BTIG | BTIG | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Oct 21, 2026 |
| Needham | Needham | Buy Reiterates $9 | Buy | Reiterates | $9 | +356.85% | Aug 18, 2026 |
Financial Forecast
Revenue This Year
1.23M
from 4.05M
Decreased by -69.61%
Revenue Next Year
5.63M
from 1.23M
Increased by 357.11%
EPS This Year
-0.79
EPS Next Year
-0.67
from -0.79
EPS and Forward PE are based on non-GAAP adjusted numbers.